(Q38445646)

English

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

scientific article published on 13 October 2004

In more languages
default for all languages
No label defined

No description defined

Statements

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer (English)
Patricia M Lorusso
David Waterhouse
J Randolph Hecht
Mary Varterasian
Eric P Kaldjian
David Y Mitchell
Judith S Sebolt-Leopold

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit